The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective … (NCT06635967) | Clinical Trial Compass
RecruitingNot Applicable
The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus
China120 participantsStarted 2024-05-21
Plain-language summary
The aim of this study is to compare the efficacy of frequency-specific patterned repetitive transcranial magnetic stimulation (rTMS) and 1Hz rTMS for the treatment of chronic subjective tinnitus. In this single-blind randomized controlled study, patients will be randomly assigned 1:1 to receive two different types of rTMS stimulation.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adults aged between 18 and 80 years old.
✓. Experiencing persistant subjective tinnitus for at least 3 months.
✓. A score of 38 or more on THI.
✓. 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear.
✓. Voluntarily participate in the study and sign the informed consent form.
✓. Have normal mental status and cognitive function, and be able to cooperate with the research process.
Exclusion criteria
✕. Diagnosis of Meniere's disease, conductive hearing loss or objective tinnitus.
✕. History of epilepsy or stroke.
✕. Diagnosis of acoustic neuroma.
✕. Severe sensorineural hearing loss.
✕. Surgically or traumatically implanted ferromagnetic foreign bodies, including but not limited to pacemakers, neurostimulators, prosthetic metal heart valves, aneurysm clips (non-titanium alloy), intraocular metal foreign bodies, cochlear implants, metal prostheses, metal joints, fixed steel plates or steel pins.
✕. Patients with active metal foreign bodies (metal implants, dentures, contraceptive rings), insulin pumps, etc., who have been evaluated in detail and are at risk for rTMS treatment.